aTYR PHARMA INC 4
4 · aTYR PHARMA INC · Filed Jan 29, 2016
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Blake John T
Vice President, Finance
Transactions
- Award
Employee Stock Option (right to buy)
2016-01-27+20,000→ 20,000 totalExercise: $6.14Exp: 2026-01-27→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 1, 2016, such that this option will be fully exercisable on January 1, 2020. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.